US 12091449
Anti-PfRH5 antibodies and antigen-binding fragments thereof
granted A61KA61K2039/505A61K31/4706
Quick answer
US patent 12091449 (Anti-PfRH5 antibodies and antigen-binding fragments thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K31/4706, A61K39/015, A61K9/0019